Researchers repurpose drug to deny drug-resistant fungus of iron, an element crucial to its survival
How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.
To treat Candida albicans, a common yeast that can cause illness in those with weakened immune systems, researchers limited the fungus’ access to iron, an element crucial to the organism’s survival.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy.”Mira Edgerton, research professor in the Department of Oral Biology at the UB School of Dental Medicine
They did so by using deferasirox, a medication used to treat blood disorders. Tested in mice, the results were promising: investigators decreased iron levels in saliva by four times, which altered the expression of more than 100 genes by the fungus, diminished its ability to infect oral mucosal tissue and caused a two-fold reduction in the organism’s survival rate.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy,” says Mira Edgerton, DDS, PhD, co-lead investigator of the study and research professor in the Department of Oral Biology at the UB School of Dental Medicine.
Edgerton, along with Sumant Puri, PhD, co-lead investigator and assistant professor in the Kornberg School of Dentistry at Temple University, published the study in March in Antimicrobial Agents and Chemotherapy.
Currently, only three major classes of clinical antifungal drugs exist. However, fungal drug resistance has steadily increased and no new classes of antifungals have emerged in decades, says Edgerton.
Candida albicans, a fungus among the group building resistance, is the agent behind a number of infections. They include oral thrush, a yeast infection in the mouth identified by a white film that coats the tongue and throat, causing painful swallowing; and denture-related stomatitis, a fungal infection that affects nearly two-thirds of U.S. denture wearers that causes inflammation, redness and swelling in the mouth.
The yeast is also the fourth leading cause of hospital-acquired bloodstream infections, which often have high mortality rates, says Edgerton.
Candida albicans is the most abundant fungus in the oral microbiome and relies heavily on saliva as a source for essential elements. Iron, the second most abundant metal in saliva, is a critical nutrient used by the fungus in several cellular processes, including energy production and DNA repair.
In mice, the group added deferasirox to drinking water to lower iron levels in saliva and reduce the availability of iron needed to sustain an infection.
The investigators found that Candida albicans in the mice who received the treatment were less likely to survive attacks by the immune system, subsisting at a 12 percent survival rate compared to a 25 percent survival rate in mice who did not receive the treatment.
The therapy also altered the expression of 106 genes by the fungus, a quarter of which were involved in the regulation of iron metabolism, directly regulated by iron or had iron-related functions. The study is the first report of iron starvation affecting gene expression of Candida albicans in real time during live infection, says Puri.
Other research has shown that treatment with deferasirox does not result in iron deficiency in adults with normal iron levels, forming the potential for preventative treatment for those who are also vulnerable to mucosal infections, says Puri.
The Latest on: Drug-resistant fungal infections
via Google News
The Latest on: Drug-resistant fungal infections
- The Post-Antibiotic Era Isn’t Coming, It’s Already Here: Startling Report Reveals Scope Of Superbug Crisison November 14, 2019 at 7:44 am
... Infections Pose Greater Threat Than Estimated The CDC added two germs to its "urgent threat" infection list since the 2013 report: a drug-resistant form of candida auris and carbapenem-resistant ...
- Daily on Healthcare, presented by SBEC: Antibiotic-resistant infections are killing far more people than realizedon November 14, 2019 at 7:01 am
ABOUT 35,000 AMERICANS DIE ANNUALLY OF DRUG-RESISTANT INFECTIONS: Antibiotic-resistant bacteria cause about 2.8 ... On the bright side, efforts to stem the spread of bacterial and fungal infections in ...
- New York names facilities that treated drug-resistant funguson November 14, 2019 at 6:03 am
NEW YORK (AP) — New York is the first state to release the names of medical facilities that have treated patients with a deadly, drug-resistant fungus that is spreading ... told the newspaper that ...
- NY Names Facilities That Treated Patients With Deadly, Drug-Resistant Fungus That’s Spreadingon November 13, 2019 at 8:16 pm
Michael Craig, an antibiotic resistance expert for the Centers for Disease Control and Prevention, told the newspaper that someone in the United States dies of a resistant infection every 15 minutes .
- New York Identifies Hospitals and Nursing Homes With Deadly Funguson November 13, 2019 at 3:04 pm
pharmaceutical and farming economies are built on the use of millions of tons of antibiotics and antifungal drugs. Without change, the United Nations estimates that drug-resistant infections will kill ...
- CDC report: 35,000 Americans die of antibiotic-resistant infections each yearon November 13, 2019 at 10:12 am
Most of the pathogens — things like drug-resistant tuberculosis and Shigella, which causes diarrhea — were listed in the middle category, serious threats. A new addition vaulted onto the list in the ...
- Deadly superbugs pose greater threat than previously estimatedon November 13, 2019 at 10:08 am
The other new urgent threat is C. auris, a fungus that can cause life-threatening infections if it gets into the bloodstream. It spreads easily among hospitalized patients and nursing home residents.
- Dangerous superbugs kill more people than previously thoughton November 13, 2019 at 10:01 am
"Some of these infections are now affecting healthier populations, which is a growing concern for us," Caig said. The report highlights five types of drug-resistant organisms the CDC deems "urgent ...
- SCYNEXIS Reports Third Quarter 2019 Financial Results and Provides Company Updateon November 12, 2019 at 4:06 pm
Dr. Taglietti continued: "We are also enthusiastically advancing our hospital-based development programs of ibrexafungerp as a novel treatment to fight invasive, increasingly drug-resistant and often ...
- Cidara Therapeutics Hosting Key Opinion Leader Meeting on Rezafungin and Cloudbreak Programson November 5, 2019 at 7:23 am
Dr. Clancy is engaged in four inter-related areas of investigation: a) medical mycology (study of fungal infections); b) extensively-drug resistant (XDR) Gram negative bacterial infections and ...
via Bing News